2.36 USD
-3.62 (-60.54%)
2.4 USD
+0.04 (+1.69%)
Taking everything into account, CODX scores 4 out of 10 in our fundamental rating. CODX was compared to 185 industry peers in the Health Care Equipment & Supplies industry. CODX has a great financial health rating, but its profitability evaluates not so good. CODX is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year CODX has reported negative net income.
- CODX had a negative operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: CODX reported negative net income in multiple years.
- The reported operating cash flow has been mixed in the past 5 years: CODX reported negative operating cash flow in multiple years.
1.2 Ratios
- With a Return On Assets value of -71.93%, CODX is not doing good in the industry: 74.05% of the companies in the same industry are doing better.
- Looking at the Return On Equity, with a value of -80.80%, CODX is doing worse than 60.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -71.93% | ||
| ROE | -80.8% | ||
| ROIC | N/A |
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 34.04%, CODX is not doing good in the industry: 74.05% of the companies in the same industry are doing better.
- In the last couple of years the Gross Margin of CODX has grown nicely.
- The Profit Margin and Operating Margin are not available for CODX so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.04% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
2. Health
2.1 Basic Checks
- CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
- CODX has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, CODX has more shares outstanding
- CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 13.52 indicates that CODX is not in any danger for bankruptcy at the moment.
- CODX has a better Altman-Z score (13.52) than 92.97% of its industry peers.
- CODX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.52 |
ROIC/WACCN/A
WACC9.93%
2.3 Liquidity
- CODX has a Current Ratio of 3.81. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
- CODX has a better Current ratio (3.81) than 67.03% of its industry peers.
- A Quick Ratio of 3.51 indicates that CODX has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.51, CODX is in the better half of the industry, outperforming 70.81% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.51 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 22.05% over the past year.
- Looking at the last year, CODX shows a very negative growth in Revenue. The Revenue has decreased by -93.06% in the last year.
- Measured over the past years, CODX shows a very strong growth in Revenue. The Revenue has been growing by 79.52% on average per year.
EPS 1Y (TTM)22.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%
3.2 Future
- Based on estimates for the next years, CODX will show a very strong growth in Earnings Per Share. The EPS will grow by 51.41% on average per year.
- CODX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 101.21% yearly.
EPS Next Y36.81%
EPS Next 2Y27.84%
EPS Next 3Y17.9%
EPS Next 5Y51.41%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for CODX. In the last year negative earnings were reported.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CODX. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as CODX's earnings are expected to grow with 17.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.84%
EPS Next 3Y17.9%
5. Dividend
5.1 Amount
- CODX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
2.36
-3.62 (-60.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-25 2026-03-25/amc
Inst Owners18.52%
Inst Owner Change0%
Ins Owners5.87%
Ins Owner Change5.92%
Market Cap143.70M
Revenue(TTM)507.90K
Net Income(TTM)-32.18M
Analysts80
Price TargetN/A
Short Float %1.13%
Short Ratio0.02
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)32.8%
Min EPS beat(2)1.96%
Max EPS beat(2)63.63%
EPS beat(4)3
Avg EPS beat(4)22.62%
Min EPS beat(4)-3.81%
Max EPS beat(4)63.63%
EPS beat(8)5
Avg EPS beat(8)-4.35%
EPS beat(12)7
Avg EPS beat(12)-30.05%
EPS beat(16)10
Avg EPS beat(16)-21.09%
Revenue beat(2)1
Avg Revenue beat(2)0.65%
Min Revenue beat(2)-5.23%
Max Revenue beat(2)6.54%
Revenue beat(4)1
Avg Revenue beat(4)-36.65%
Min Revenue beat(4)-86.85%
Max Revenue beat(4)6.54%
Revenue beat(8)3
Avg Revenue beat(8)53.36%
Revenue beat(12)4
Avg Revenue beat(12)112.38%
Revenue beat(16)5
Avg Revenue beat(16)77.24%
PT rev (1m)0%
PT rev (3m)-37.5%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4%
EPS NY rev (1m)0%
EPS NY rev (3m)7.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-16%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 282.93 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.61 | ||
| P/tB | 10.47 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.41
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.51
OCFYN/A
SpS0.01
BVpS0.65
TBVpS0.23
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -71.93% | ||
| ROE | -80.8% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 34.04% | ||
| FCFM | N/A |
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
F-Score2
Asset Turnover0.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 53.59% | ||
| Cap/Sales | 126.23% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.81 | ||
| Quick Ratio | 3.51 | ||
| Altman-Z | 13.52 |
F-Score2
WACC9.93%
ROIC/WACCN/A
Cap/Depr(3y)92.34%
Cap/Depr(5y)204.81%
Cap/Sales(3y)14.45%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y36.81%
EPS Next 2Y27.84%
EPS Next 3Y17.9%
EPS Next 5Y51.41%
Revenue 1Y (TTM)-93.06%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-77.38%
Revenue Next Year-88.3%
Revenue Next 2Y-62.71%
Revenue Next 3Y60.7%
Revenue Next 5Y101.21%
EBIT growth 1Y11.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-41.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-46.26%
OCF growth 3YN/A
OCF growth 5YN/A
CO-DIAGNOSTICS INC / CODX FAQ
What is the ChartMill fundamental rating of CO-DIAGNOSTICS INC (CODX) stock?
ChartMill assigns a fundamental rating of 4 / 10 to CODX.
What is the valuation status of CO-DIAGNOSTICS INC (CODX) stock?
ChartMill assigns a valuation rating of 0 / 10 to CO-DIAGNOSTICS INC (CODX). This can be considered as Overvalued.
What is the profitability of CODX stock?
CO-DIAGNOSTICS INC (CODX) has a profitability rating of 1 / 10.
How financially healthy is CO-DIAGNOSTICS INC?
The financial health rating of CO-DIAGNOSTICS INC (CODX) is 8 / 10.